Testa, L. (2021) “Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy”, Clinics, 76, p. e3146. doi:10.6061/clinics/2021/e3146.